DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADB274478
Title:
The Role of VDR in Phosphorylation in Vitamin D-Induced Apoptosis
Corporate Author:
NOTRE DAME UNIV IN
Report Date:
2001-07-01
Abstract:
Vitamin D3 compounds offer an alternative approach to anti-hormonal therapies for human breast cancer. l,25-Dihydroxyvitrnain D3 1 ,25-D3 acts through the nuclear vitamin D receptor VDR, a phosphoprotein, which can be phosphorylated by protein kinase C PKC and casein kinase II to modulate gene expression. Our lab has shown that 1 ,2S-D3 induces apoptosis in MCF-7 cells by disruption of initochondrial function which is associated with Bax translocation to mitochondria, cytocinome C release, and production of reactive oxygen species ROS. Fluorescence microscopy showed direct evidence of Bax translocation to the initochondria after treatment with 1 ,25-D3 in MCF-7 cells. TPA a PKC activator did not induce cytocinome C release or Bax translocation, thus demonstrating that it has no effect on mitochondria. However, when the MCF-7D3Res cells a vitamin D3-resistant variant were treated with 1 ,25-D3 in the presence of TPA, the cells displayed apoptotic morphology and redistribution of both cytochrome C and Bax. The observation that the phorbol ester TPA can sensitize the vitamin D3-resistant variant to the effects of 1 ,25-D3 suggests an important role for phosphorylation in dictating sensitivity to vitamin D3 mediated apoptosis. This study indicates that the effects of 1 ,25-D3 on mitochondrial disruption might be sensitized through activators of PKC.
Descriptive Note:
Annual summary rept. 1 Jul 1998-30 Jun 2001
Pages:
0042
Contract Number:
DAMD17-97-1-7183
File Size:
3.26MB
